Sarepta Therapeutics (SRPT) Stock Price

$106.3 0%

Sign up
to add to portfolio

AI Score

Hold

  • Alternative

    7

  • Fundamental

    3

  • Technical

    3

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on Sarepta Therapeutics, AI stock picks, stock alerts and much more.

Sign up

SRPT AI Stock Analysis

AI stock analysis for SRPT is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Sarepta Therapeutics (SRPT) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Sarepta Therapeutics (SRPT) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Sarepta Therapeutics (SRPT), currently trading at $106.3, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About SRPT

LSE

  • Sarepta Therapeutics, Inc.

  • Symbol

    SRPT

  • Market

    NASDAQ

  • Industry

    Biotechnology

  • Market Cap

    10.2B

Similar Stocks

CPRX Catalyst Pharmaceuticals
CPRX		 $21.62
2%
6
INO Inovio Pharmaceuticals
INO		 $2.24
0.9%
2
MRNA Moderna
MRNA		 $35.53
5.3%
4
AVXL Anavex Life Sciences
AVXL		 $8.35
3.8%
6
BBIO BridgeBio Pharma
BBIO		 $36.85
0.1%
6

News

Down -8.52% in 4 Weeks, Here's Why Sarepta Therapeutics (SRPT) Looks Ripe for a Turnaround

Down -8.52% in 4 Weeks, Here's Why Sarepta Therapeutics (SRPT) Looks Ripe for a Turnaround
February 17, 2025. zacks.com
Sarepta Therapeutics Announces Results from Part 2 of the EMBARK Study Demonstrating Sustained Benefits and Disease Stabilization in Ambulatory Individuals with Duchenne Muscular Dystrophy Following Treatment with ELEVIDYS

Sarepta Therapeutics Announces Results from Part 2 of the EMBARK Study Demonstrating Sustained Benefits and Disease Stabilization in Ambulatory Individuals with Duchenne Muscular Dystrophy Following Treatment with ELEVIDYS
January 27, 2025. businesswire.com
SRPT Stock Rises 23% in a Year: Time to Buy, Hold or Sell?

SRPT Stock Rises 23% in a Year: Time to Buy, Hold or Sell?
January 6, 2025. zacks.com
Sarepta wins $115.2 million US drug patent verdict from Japan's Nippon Shinyaku

Sarepta wins $115.2 million US drug patent verdict from Japan's Nippon Shinyaku
December 20, 2024. reuters.com

SRPT Alternative Data

Web Traffic

Sarepta Therapeutics receives an estimated 41058 monthly visitors to sarepta.com.

  • Web Traffic

    41058

  • Change from Previous Month

    21.1%

  • 3 Month Change

    22.7%

  • YoY Change

    22.7%

News Mentions

Sarepta Therapeutics was mentioned 0 times in the news yesterday.

  • News Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    100%

  • 3 Month Change

    100%

Reddit Mentions

Sarepta Therapeutics has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • Daily Change

    0%

Twitter Followers

Sarepta Therapeutics has 5,770 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.2% over the last month.

  • Twitter Followers

    5770

  • Daily Change

    0%

  • 1 Month Change

    0.2%

  • 3 Month Change

    1.3%

  • YoY Change

    1.3%

Facebook Engagement

Sarepta Therapeutics has engaged 623 users via their Facebook Page over the last 7 days.

  • Facebook Engagement

    623

  • Daily Change

    15.6%

  • 1 Month Change

    52.3%

  • 3 Month Change

    36%

  • YoY Change

    36%

Instagram Followers

Sarepta Therapeutics has 5,387 Instagram Followers on its main Instagram account, up by 0.8% over the last month.

  • Instagram Followers

    5387

  • Daily Change

    0%

  • 1 Month Change

    0.8%

  • 3 Month Change

    2.7%

  • YoY Change

    2.7%

LinkedIn Followers

116,454 are following Sarepta Therapeutics on LinkedIn, up by 1.3% over the last month.

  • LinkedIn Followers

    116454

  • Daily Change

    0%

  • 1 Month Change

    1.3%

  • 3 Month Change

    3.7%

Job Postings

Sarepta Therapeutics currenly has an estimated 65 open job postings, up by 85.7% over the last month.

  • Job Postings

    65

  • Daily Change

    7.1%

  • 1 Month Change

    85.7%

  • 3 Month Change

    132.1%

  • YoY Change

    132.1%

LinkedIn Employees

According to LinkedIn, Sarepta Therapeutics has 1,525 employees, up by 1.1% over the last month.

  • LinkedIn Employees

    1525

  • Daily Change

    0%

  • 1 Month Change

    1.1%

  • 3 Month Change

    3.1%

  • YoY Change

    3.1%

Business Outlook

  • Business Outlook

    86

  • Change from Previous Month

    11.3%

  • 3 Month Change

    0%

  • YoY Change

    0%

SRPT Financials

SRPT Key Metrics

  • Total Revenue

    $467.2M

  • Net Income

    $33.6M

  • Earnings per Share

    $0.35

  • Free cash flow

    -$98M

  • EBITDA

    $22.2M

  • EBITDA Ratio

    0.0475114

  • Total Assets

    $3.6B

SRPT 2-year Revenue & Income
SRPT 2-year Free Cash Flow

SRPT Technicals

SRPT SMA
SRPT RSI

FAQ

What's the current price of Sarepta Therapeutics (SRPT) Stock?
The price of an Sarepta Therapeutics (SRPT) share is $106.3.

What's the market cap of Sarepta Therapeutics?
The current market cap of Sarepta Therapeutics is 10.2B.

Should I buy or sell SRPT?
Sarepta Therapeutics shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Sarepta Therapeutics is better viewed as a hold or accumulate position while waiting for further developments.

Is Sarepta Therapeutics a good investment?
The current analysis of Sarepta Therapeutics' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Sarepta Therapeutics' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.

Is now a good time to buy Sarepta Therapeutics (SRPT) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Sarepta Therapeutics stock is currently neutral, suggesting a cautious approach might be wise.

What are some stocks similar to Sarepta Therapeutics (SRPT) that investors often compare it to?
Sarepta Therapeutics (SRPT) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.

What is the forecast for Sarepta Therapeutics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Sarepta Therapeutics' stock price to be around $105.7 in 2026. Starting from the current price of $106.3, this represents a 0.5% change in price, indicating a neutral outlook for the stock.

How to buy Sarepta Therapeutics (SRPT) Stock?
Sarepta Therapeutics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Sarepta Therapeutics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.